Fundamental Analysis of Acer Therapeutics Inc - Growth / Value Index


ACER - Valuation Highlights

Valuation Analysis

   Tsr Value Index - Very Poor Score of 5.00
   Book Value in last 3 years is trending down
   Book value is negative
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning -0.228 -0.397 35.25 %
Price to Book -0.540 -0.621 88.64 % -0.338
Price to Sales 31.09 0 0 %
Enterprise Value to EBITDA Multiple 0 -0.754 -471.01 %


ACER - Profitability Highlights

Profitability Analysis

   Excellent QoQ /QoQ FY EPS growth
   Strong Return On Capital Employed of 509.81
   Company Earning excess return
   Reasonable Dividend Yield of 3.50 %
   Tsr Profitability Index - Very Poor Score of 5.00
   Piotroski F Score - Very Poor Value of 1.0
   Negative Net profit for last two years
   Company Net profit is Negative for last 5 Quarters
   In the last three years, the company has given poor Net Margin
   In the last three years, the company has given poor Returns on Equity
   In the last three years, the company has given poor Returns on Assets
   Negative Net Margin MRQ
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 0 0 0 % 0
Return On Asset -571.73 -225.71 -432.30 % -105.21
Net Profit Margin -13631.53 0 0 % -3962.25
Operating Profit Margin -5960.82 0 0 % -3463.77
EBITDA Margin -5960.82 0 0 % -3463.77


Highlights
Market Cap16148.49 K
Enterprise Value25434.03 K
Price/Book TTM-0.540
Outstanding Share24463.70 K
Float/ Outstanding Share75.09%
Dividend Yield3.50 %
Share Holding
Guru Numbers
Price/Graham No0
Peter Lynch Ratio0
Piotroski F Score1.00
Altman Z Score-25.64
Sloan Ratio0.345
Peter Lynch Fair Value0


ACER - Growth Highlights

Growth Analysis

   Quarterly sales in last 5 years is trending up
   Tsr Growth Index - Very Poor Score of 5.00
   Annual sales in last 3 years is trending down
   Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 371790 M 100.00 % %
Gross Profit 287985 M 100.00 % %
EBITDA -22161.74 B 70.79 % 199.87 %
Net Profit -50680.66 B 70.66 % 82.08 %
EPS -2.89 54.44 % NA


ACER - Stability Highlights

Stability Analysis

   Debt to equity ratio has decreased and is lowest in last five years
   Tsr Stability Index - Very Poor Score of 5.00
   Altman Z Score of -25.64 suggest high risk
   Company is unable to generate enough free cash to support the business.
   Interest Coverage of -258.32
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio -0.693 -547.92 % -0.380
Cash Ratio 0.123 -71.85 %
Quick Ratio 0 0 % 0.0152
Shareholders Equity -144.19 -2933.17 %
Debt to EBITDA -0.444 -3589.21 %


Historical Valuation Ratios of Acer Therapeutics Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Acer Therapeutics Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Acer Therapeutics Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Acer Therapeutics Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)